Recent evidence on Castleman disease (Medscape AI)

https://www.medscape.com/ai-search?query=Recent%20evidence%20on%20Castleman%20disease&ecd=wnl_tp10_daily_251214_MSCPEDIT_etid7950593&uac=148436CN&impID=7950593 Castleman disease (CD) comprises a heterogeneous group of lymphoproliferative disorders characterized by distinctive histopathologic changes and systemic inflammation driven largely by interleukin-6 (IL-6). Recent summaries of CD underscore its variable epidemiology, subtypes, pathophysiology, clinical features, diagnostic approach, and management strategies.